Dyne Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
25.00
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
3
|
|
# Buys
|
3
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.92
|
-0.80
|
0.12
|
13.04%
|
|
2022-06-30
|
-0.77
|
-1.01
|
-0.24
|
-31.17%
|
|
2022-03-31
|
-0.88
|
-0.69
|
0.19
|
21.59%
|
|
2021-12-31
|
-0.99
|
-1.00
|
-0.01
|
-1.01%
|
|
2021-09-30
|
-0.64
|
-0.83
|
-0.19
|
-29.69%
|
|
2021-06-30
|
-0.55
|
-0.58
|
-0.03
|
-5.45%
|
|
2021-03-31
|
-0.60
|
-0.50
|
0.10
|
16.67%
|
|
2020-12-31
|
-0.37
|
-0.64
|
-0.27
|
-72.97%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.50
|
|
2021-12-31
|
-2.91
|
|
2020-12-31
|
-3.04
|
|
2017-12-31
|
-2.40
|
|
2016-12-31
|
-3.06
|